KLP Kapitalforvaltning’s Madrigal Pharmaceuticals MDGL Stock Holding History

KLP Kapitalforvaltning’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.75M	Buy	3,480 +120	+4%	+$63.4K	0.01%	823
2026 Q2	$1.8M	Buy	3,360 +120	+4%	+$61.5K	0.01%	831
2026 Q1	$1.7M	Hold	3,240	–	–	0.01%	775
2025 Q4	$1.89M	Buy	3,240 +240	+8%	+$123K	0.01%	741
2025 Q3	$1.38M	Hold	3,000	–	–	0.01%	849
2025 Q2	$908K	Buy	3,000 +400	+15%	+$119K	﹤0.01%	1037
2025 Q1	$861K	Hold	2,600	–	–	﹤0.01%	1009
2024 Q4	$802K	Buy	+2,600	New	+$731K	﹤0.01%	1091

Other funds holding MDGL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

KLP Kapitalforvaltning's MDGL Position: Q3 2026 in Review

KLP Kapitalforvaltning increased its Madrigal Pharmaceuticals (MDGL) stake by 3.6% in Q3 2026, buying an estimated $63.4K and bringing the position to 3,480 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #823.

KLP Kapitalforvaltning first reported a position in MDGL in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.89M in Q4 2025. 226 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

KLP Kapitalforvaltning held 3,480 shares of Madrigal Pharmaceuticals worth $1.75M as of Q3 2026.
KLP Kapitalforvaltning bought 120 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $63.4K.
Madrigal Pharmaceuticals made up 0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #823 holding.
KLP Kapitalforvaltning first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
KLP Kapitalforvaltning's Madrigal Pharmaceuticals position peaked at $1.89M in Q4 2025.
226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.